Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 28 Dec 2023

Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor model

in Cancer Immunity and Immunotherapy

J. Bryan Iorgulescu
Neil Ruthen
Ryuhjin Ahn
Eleni Panagioti
Prafulla C. Gokhale
Martha Neagu
Maria C. Speranza
Benjamin K. Eschle
Kara M. Soroko
Raziye Piranlioglu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1297932

8,126 views
3 citations

Original Research

Published on 22 Dec 2023

Comparison of neoadjuvant chemoimmunotherapy and chemotherapy alone for resectable stage III non-small cell lung cancer: a real-world cohort study

in Cancer Immunity and Immunotherapy

Sihao Zhou
Yi Liu
Kejun Liu
Junkai Zhang
Hanlin Liang
Yingmeng Wu
Hongyu Ye
Yi Liang
Jingjing Zhang
Weizhao Huang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1343504

2,613 views
1 citation

Review

Published on 22 Dec 2023

Biomarkers predicting the efficacy of immune checkpoint inhibitors in hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Ran Qin
Tianqiang Jin
Feng Xu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1326097

5,652 views
9 citations

Review

Published on 22 Dec 2023

The next bastion to be conquered in immunotherapy: microsatellite stable colorectal cancer

in Cancer Immunity and Immunotherapy

Kai Ding
Pei Mou
Zhe Wang
Shuqing Liu
JinPei Liu
Hao Lu
Ganjun Yu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1298524

6,932 views
11 citations

Original Research

Published on 22 Dec 2023

ATF5 promotes malignant T cell survival through the PI3K/AKT/mTOR pathway in cutaneous T cell lymphoma

in Cancer Immunity and Immunotherapy

Mengzhou Cao
Pan Lai
Xiangjun Liu
Fengjie Liu
Yao Qin
Ping Tu
Yang Wang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1282996

4,544 views
6 citations

Original Research

Published on 22 Dec 2023

Neutrophil infiltration associated genes on the prognosis and tumor immune microenvironment of lung adenocarcinoma

in Cancer Immunity and Immunotherapy

Renwang Liu
Guangsheng Zhu
Yonglin Sun
Mingbiao Li
Zixuan Hu
Peijun Cao
Xuanguang Li
Zuoqing Song
Jun Chen

Frontiers in Immunology

doi 10.3389/fimmu.2023.1304529

6,644 views
15 citations

Review

Published on 22 Dec 2023

Current status and future challenges of CAR-T cell therapy for osteosarcoma

in Cancer Immunity and Immunotherapy

Shizhe Li
He Zhang
Guanning Shang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1290762

6,964 views
13 citations

Original Research

Published on 22 Dec 2023

Inhibition of ERO1a and IDO1 improves dendritic cell infiltration into pancreatic ductal adenocarcinoma

in Cancer Immunity and Immunotherapy

Apple Hui Min Tay
Riccardo Cinotti
Newman Sui Kwan Sze
Andreas Lundqvist

Frontiers in Immunology

doi 10.3389/fimmu.2023.1264012

3,362 views
3 citations

Original Research

Published on 22 Dec 2023

Gemtuzumab ozogamicin for relapsed or primary refractory acute myeloid leukemia in children—the Polish Pediatric Leukemia and Lymphoma Study Group experience

in Cancer Immunity and Immunotherapy

Katarzyna Pawinska-Wasikowska
Malgorzata Czogala
Szymon Skoczen
Marta Surman
Monika Rygielska
Teofila Ksiazek
Agnieszka Pac
Aleksandra Wieczorek
Jolanta Skalska-Sadowska
Magdalena Samborska

Frontiers in Immunology

doi 10.3389/fimmu.2023.1268993

4,272 views
2 citations

Review

Published on 21 Dec 2023

Ovarian cancer treatment and natural killer cell-based immunotherapy

in Cancer Immunity and Immunotherapy

Zhongru Fan
Dongyu Han
Xin Fan
Lin Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2023.1308143

8,963 views
14 citations

Original Research

Published on 21 Dec 2023

Peripheral T lymphocyte and immunocyte subset dynamics: markers of neoadjuvant therapy outcomes in esophageal squamous cell carcinoma

in Cancer Immunity and Immunotherapy

Xin Nie
Shuya He
Xinming Nie
Changding Li
Kunyi Du
Wenwu He
Zhiyu Li
Kunhan Ni
Simiao Lu
Chenghao Wang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1320282

2,017 views

General Commentary

Published on 20 Dec 2023

Commentary: PFKFB3 overexpression in monocytes of patients with colon but not rectal cancer programs pro-tumor macrophages and is indicative for higher risk of tumor relapse

in Cancer Immunity and Immunotherapy

Nikolay Shakhpazyan
Liudmila Mikhaleva
Arcady Bedzhanyan
Nikolay Sadykhov
Konstantin Midiber
Alexander Orekhov

Frontiers in Immunology

doi 10.3389/fimmu.2023.1290459

1,461 views
1 citation

Case Report

Published on 20 Dec 2023

Making “cold” tumors “hot”- radiotherapy remodels the tumor immune microenvironment of pancreatic cancer to benefit from immunotherapy: a case report

in Cancer Immunity and Immunotherapy

Fan Tong
Yi Sun
Yahui Zhu
Huizi Sha
Jiayao Ni
Liang Qi
Qing Gu
Chan Zhu
Wenjing Xi
Baorui Liu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1277810

2,748 views
3 citations

Correction

Published on 20 Dec 2023

Corrigendum: Targeting innate immunity in breast cancer therapy: a narrative review

in Cancer Immunity and Immunotherapy

Yanqi Ye
Chun Xu
Fengqian Chen
Qi Liu
Ning Cheng

Frontiers in Immunology

doi 10.3389/fimmu.2023.1353708

887 views
1 citation

Original Research

Published on 20 Dec 2023

SON-1210 - a novel bifunctional IL-12 / IL-15 fusion protein that improves cytokine half-life, targets tumors, and enhances therapeutic efficacy

in Cancer Immunity and Immunotherapy

John K. Cini
Susan Dexter
Darrel J. Rezac
Stephen J. McAndrew
Gael Hedou
Rich Brody
Rukiye-Nazan Eraslan
Richard T. Kenney
Pankaj Mohan

Frontiers in Immunology

doi 10.3389/fimmu.2023.1326927

6,431 views
6 citations

Mini Review

Published on 20 Dec 2023

Targeting Trop2 in solid tumors: a look into structures and novel epitopes

in Cancer Immunity and Immunotherapy

Xinlin Liu
Jiyixuan Li
Junwen Deng
Jianan Zhao
Gaoxiang Zhao
Tingting Zhang
Hongfei Jiang
Bing Liang
Dongming Xing
Jie Wang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1332489

11,971 views
11 citations